The impact of obesity on metabolic and cardiovascular health: A morphometric retrospective cohort study
Obesity and cardiovascular risk
Keywords:
Obesity, metabolic profile, morphometric parameters, heartAbstract
Background/Aim: Obesity is recognized as a significant risk factor for various diseases, including cardiovascular disease. The link between obesity and adverse health outcomes, particularly cardiovascular ailments, underscores the need for a comprehensive understanding of the associated metabolic and cardiovascular markers. This study aimed to compare individuals with obesity and those without obesity in terms of markers related to metabolism and cardiovascular health.
Methods: 136 participants were enrolled in the analysis, comprising 83 individuals with obesity and 53 individuals without obesity. The participants' demographic data and biochemical test results were collected, including age, sex, fasting glucose, creatinine, cholesterol, triglyceride, and body mass index (BMI). Measurements were taken for various cardiac markers using echocardiographic images. Morphometric parameters of the heart, such as left ventricular (LV) and right ventricular (RV) end-systolic-and-diastolic diameter, ejection fraction, interventricular septum thickness, aortic ascending diameter, and epicardial fat tissue thickness were assessed. Statistical analyses were employed to identify significant differences. Independent-sample t-tests and Pearson correlation tests were used for comparisons between obese and non-obese individuals.
Results: Comparisons between obese and non-obese individuals revealed that individuals with obesity exhibited significantly higher levels of fasting glucose (P=0.021), triglycerides (P=0.014), and epicardial fat tissue thickness (P˂0.001). LV ejection fraction was significantly higher in obese individuals than in non-obese participants (P˂0.001) but remained within the normal range. Sex-associated differences in metabolic variables of obesity and non-obesity revealed that the obese male individuals had higher fasting glucose (P˂0.001) and triglyceride levels (P˂0.001) compared to obese female individuals. Moreover, BMI was positively correlated with epicardial fat tissue thickness (r2=0.29, P˂0.001), and triglyceride level was significantly correlated with fasting glucose level (r2=0.19, P˂0.001).
Conclusion: The study design allowed for a comparison between obese and non-obese individuals, providing valuable insights into the differences in these markers based on obesity status. The investigation of individuals with elevated BMI levels highlights significant deviations in crucial indicators compared to those with normal levels. These findings emphasize the urgent need to address obesity as a central contributor to the development of diverse diseases and advocate for proactive strategies aimed at mitigating associated health risks.
Downloads
References
Poirier P, Giles TD, Bray GA, Hong Y, Stern JS, Pi-Sunyer FX, et al. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation. 2006;113:898-918. DOI: https://doi.org/10.1161/CIRCULATIONAHA.106.171016
Alpert MA, Lavie CJ, Agrawal H, Aggarwal KB, Kumar SA. Obesity and heart failure: epidemiology, pathophysiology, clinical manifestations, and management. Translational Research. 2014;164:345-56. DOI: https://doi.org/10.1016/j.trsl.2014.04.010
Lavie CJ, Alpert MA, Arena R, Mehra MR, Milani RV, Ventura HD. Impact of obesity and the obesity paradox on prevalence and prognosis in heart failure. J Am Coll Cardiol Heart Fail. 2013;1:93-102. DOI: https://doi.org/10.1016/j.jchf.2013.01.006
Alpert MA, Omran J, Mehra A, Ardhanari S. Impact of obesity and weight loss on cardiac performance and morphology in adults. Prog Cardiovasc Dis. 2014;56:391–400. DOI: https://doi.org/10.1016/j.pcad.2013.09.003
Abel ED, Litwin SE, Sweeney G. Cardiac remodeling in obesity. Physiol Rev. 2008;88:389-419. DOI: https://doi.org/10.1152/physrev.00017.2007
Alpert MA, Agrawal H, Aggarwal K, Kumar SA, Kumar A. Heart failure and obesity in adults: pathophysiology, clinical manifestations and management. Curr Heart Fail Rep. 2014;11:156–65. DOI: https://doi.org/10.1007/s11897-014-0197-5
Reis JP, Allen N, Gibbs BB, Gidding SS, Lee JM, Lewis CE, et al. Association of the degree of adiposity and duration of obesity with measures of cardiac structure and function: the CARDIA study. Obesity. 2014;22:2434-40. DOI: https://doi.org/10.1002/oby.20865
Stritzke J, Markus MRP, Duderstadt S, Lieb W, Luchner A, Döring A, et al. The aging process of the heart: obesity is the main risk factor for left atrial enlargement during aging: the MONICA/KORA (monitoring of trends and determinations in cardiovascular disease/cooperative research in the region of Augsburg) study. Journal of the American College of Cardiology. 2009;54:1982-9. DOI: https://doi.org/10.1016/j.jacc.2009.07.034
Movahed MR, Saito Y. Obesity is associated with left atrial enlargement E/A reversal and left ventricular hypertrophy. Exp Clin Cardiol. 2008;13:89-91.
Haslam DW, James WP. Obesity. Lancet. 2005;366(9492):1197-209. DOI: https://doi.org/10.1016/S0140-6736(05)67483-1
Neeland IJ, Yokoo T, Leinhard OD, Lavie CJ. 21st century advances in multimodality imaging of obesity for care of the cardiovascular patient. Cardiovascular Imaging. 2021;14:482-94. DOI: https://doi.org/10.1016/j.jcmg.2020.02.031
Janssen I, Katzmarzyk PT, Ross R. Waist circumference and not body mass index explains obesity-related health risks. The American journal of clinical nutrition. 2004;79:379-84. DOI: https://doi.org/10.1093/ajcn/79.3.379
Elsanhoury A, Nelki V, Kelle S, Van Linthout S, Tschöpe C. Epicardial fat expansion in diabetic and obese patients with heart failure and preserved ejection fraction—a specific HFpEF phenotype. Frontiers in Cardiovascular Medicine. 2021;8:720690. DOI: https://doi.org/10.3389/fcvm.2021.720690
Packer M. Epicardial adipose tissue may mediate the deleterious effects of obesity and inflammation on the myocardium. J Am Coll Cardiol. 2018;71:2360–72. DOI: https://doi.org/10.1016/j.jacc.2018.03.509
Garber AJ. Obesity and type 2 diabetes: Which patients are at risk? Diabetes, Obesity, and Metabolism. 2012;14:399-408. DOI: https://doi.org/10.1111/j.1463-1326.2011.01536.x
Boullart ACI, De Graaf J, Stalenhoef AF. Serum triglycerides and risk of cardiovascular disease. Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids. 2012;1821:867-75. DOI: https://doi.org/10.1016/j.bbalip.2011.10.002
Aurigemma GP, de Simone G, Fitzgibbons TP. Cardiac remodeling in obesity. Circ Cardiovasc Imaging. 2013;6:442-52. DOI: https://doi.org/10.1161/CIRCIMAGING.113.000269
Walker BR, Soderberg S, Lindahl B, Olsson T. Independent effects of obesity and cortisol in predicting cardiovascular risk factors in men and women. Journal of Internal Medicine. 2000;247:198-204. DOI: https://doi.org/10.1046/j.1365-2796.2000.00609.x
Speakman JR. Obesity: the integrated roles of environment and genetics. The Journal of Nutrition. 2004;134:2090S-2105S. DOI: https://doi.org/10.1093/jn/134.8.2090S
Wells JC, Stock JT. The biology of the colonizing ape. American Journal of Physical Anthropology. 2007;134:191-222. DOI: https://doi.org/10.1002/ajpa.20735
Ross R, Dagnone D, Jones PJ, Smith H, Paddags A, Hudson R, et al. Reduction in obesity and related comorbid conditions after diet-induced weight loss or exercise-induced weight loss in men: a randomized, controlled trial. Annals of Internal Medicine. 2000;133:92-103. DOI: https://doi.org/10.7326/0003-4819-133-2-200007180-00008
Hardcastle SJ, Taylor AH, Bailey MP, Harley RA, Hagger MS. Effectiveness of a motivational interviewing intervention on weight loss, physical activity and cardiovascular disease risk factors: a randomized controlled trial with a 12-month post-intervention follow-up. International Journal of Behavioral Nutrition and Physical Activity. 2013;10:1-16. DOI: https://doi.org/10.1186/1479-5868-10-40
Gallagher D, Heymsfield SB, Heo M, Jebb SA, Murgatroyd PR, Sakamoto Y. Healthy percentage body fat ranges an approach for developing guidelines based on body mass index. The American Journal of Clinical Nutrition. 2000;72:694-701. DOI: https://doi.org/10.1093/ajcn/72.3.694
Downloads
- 0 0
Published
Issue
Section
How to Cite
License
Copyright (c) 2024 Nurullah Yucel, Meryem Esma Duz, Tayfun Aygun, Gulam Hekimoglu, Mustafa Ahmet Huyut, Goktug Savas, Muzaffer Seker
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.